Physician-community health worker partnering to support diabetes self-management in primary care
The role of community health workers (CHWs) has expanded from outreach and education to working within a clinical team in a primary care setting. To improve self-management among patients with type 2 diabetes incorporating CHWs as members of a clinical team. A cohort of 114 patients with type 2 diab...
Gespeichert in:
Veröffentlicht in: | Quality in primary care 2010, Vol.18 (6), p.363-372 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The role of community health workers (CHWs) has expanded from outreach and education to working within a clinical team in a primary care setting.
To improve self-management among patients with type 2 diabetes incorporating CHWs as members of a clinical team.
A cohort of 114 patients with type 2 diabetes enrolled in 2007 participated in a teambased self-management intervention with followup in 2008. The study assessed whether significant changes occurred in clinical, patient satisfaction and activation measures after the intervention compared with baseline. The programme was located at St Luke's Health Care Center in San Francisco, California, in an ethnically diverse neighbourhood serving predominantly low-income Latino patients. Clinical outcomes measured included glycosylated haemoglobin (HbA1c), low-density lipoprotein (LDL), blood pressure and total cholesterol. A Patient Activation Measure (PAM) assessed self-management. Both provider and patient experiences with the programme were also assessed using a patient telephone satisfaction survey and provider focus group.
The majority of patients were Latino Spanish speaking women on public insurance. Thirty-one patients participated in a telephone satisfaction survey. Six providers participated in a focus group to assess satisfaction with care. HealthFirst had a positive impact, improving HbA1c among high-risk patients with type 2 diabetes (HbA1c≥ 9.0) and maintaining glycaemic control among patients with controlled glycaemic level at baseline (HbA1c |
---|---|
ISSN: | 1479-1072 |